What preoperative criteria should be used to assess the risk and determine eligibility for liver resection in patients with liver disease?

Preoperative Risk Assessment for Liver Resection

The most critical preoperative criterion for liver resection is ensuring adequate future liver remnant (FLR) volume: ≥20% in normal livers, 30-35% in mild steatosis/early cirrhosis (Child-Pugh A), and 40% in severe steatosis, with portal hypertension and Child-Pugh B/C being relative or absolute contraindications depending on resection extent 1.

Assessment Algorithm by Liver Disease Severity

For Patients with Normal Liver

• FLR requirement: ≥20% of total functional liver volume
• Risk of post-hepatectomy liver failure (PHLF) increases dramatically when FLR <20%: 50% PHLF rate vs 30% when FLR ≥20% 1
• Mortality risk: 11% when FLR ≤20% vs 3% when FLR 20-30% 1

For Patients with Chronic Liver Disease

Mild disease (steatosis, cholestasis, Child-Pugh A without portal hypertension):

• FLR requirement: 30-35% minimum 1
• Can proceed with resection if clinically significant portal hypertension (CSPH) is ruled out 2

Moderate disease (severe steatosis/cholestasis):

• FLR requirement: 40% minimum 1
• Consider portal vein embolization (PVE) if borderline FLR 1

Advanced cirrhosis (Child-Pugh B/C or portal hypertension):

• Even small resections carry high PHLF risk 1
• Elective major resection should be deferred 3
• Child-Pugh C generally represents an absolute contraindication 4

Essential Preoperative Workup

1. Liver Function and Portal Hypertension Assessment

• Child-Pugh score and MELD score are mandatory 4, 3
• VOCAL-Penn cirrhosis surgical risk score for comprehensive risk stratification 2, 3
• Hepatic venous pressure gradient (HVPG) measurement to confirm/exclude CSPH in cirrhotic patients 2
• Esophagogastroduodenoscopy (EGD) if CSPH not ruled out by non-invasive tests 2
• Consider indocyanine green (ICG) retention test at 15 minutes, particularly in Asian practice settings 5

2. Volumetric Assessment

• CT or MRI volumetry to calculate FLR as percentage of total functional liver volume 1
• Calculate: (Total Liver Volume - Tumor Volume) = Functional Liver Volume
• FLR = (FLR volume / Functional Liver Volume) × 100%
• 3D reconstruction software provides critical vascular/biliary anatomy 1

3. Cardiopulmonary Evaluation (especially for cirrhotic patients)

• Electrocardiogram 2
• Transthoracic echocardiography 2
• Pulse oximetry; if hypoxic, contrast echocardiography to rule out hepatopulmonary syndrome 2
• Functional capacity and frailty assessment 2, 3

4. Laboratory Parameters

Critical thresholds associated with increased mortality 6:

• INR ≥1.1 (OR 2.43 for mortality)
• Gamma-GT ≥60 U/L (OR 2.86)
• Platelet count ≤120/nL (OR 5.52)
• Creatinine ≥2 mg/dL (OR 9.85)
• Bilirubin and albumin levels

Portal Vein Embolization Strategy

Indications for PVE 1:

• Borderline FLR: <40% in fibrosis, <50% in Child-Pugh A cirrhosis without portal hypertension
• Only for Child-Pugh A patients without significant portal hypertension 1

Success criteria post-PVE 1:

• >10% FLR hypertrophy in severe liver disease (fibrosis/cirrhosis)
• >5% FLR hypertrophy in normal liver
• Inadequate hypertrophy response (<5%) predicts high PHLF risk 1
• Perform resection 4-6 weeks after PVE 1

Surgery-Specific Risk Factors

High-risk procedures 4:

• Hepatic resection (especially >3 segments)
• Intra-abdominal surgery
• Cardiothoracic surgery
• Right trisectionectomy (OR 2.88 for mortality) 6

Lower-risk procedures 4:

• Abdominal wall hernia repair
• Orthopedic surgery

Surgical approach: Laparoscopic preferred over open to minimize hepatic decompensation 2, 4

Critical Decision Points

Proceed with Resection:

• Child-Pugh A + MELD <10 + adequate FLR + no CSPH 4, 3
• Normal liver with FLR ≥20% 1

Proceed with Caution:

• Child-Pugh A + MELD 10-15 (except liver resection and cardiac surgery) 4
• Consider PVE if borderline FLR 1

Defer Elective Surgery:

• Child-Pugh C 4, 3
• Mayo risk score >15 4
• Child-Pugh B with portal hypertension 1
• Inadequate FLR despite PVE 1

Common Pitfalls

Volume is not function: While FLR volume is the strongest predictor, it's a surrogate for function 1. In cirrhotic patients, even adequate volume may not guarantee adequate function.

Chemotherapy effects: Neoadjuvant chemotherapy (oxaliplatin, irinotecan) causes hepatotoxicity but is often reversible; benefits may outweigh risks 1. Factor this into FLR calculations.

Intraoperative factors matter: Blood loss >1000 mL, prolonged ischemia, and need for transfusion independently increase PHLF risk 1. Optimize surgical technique and anesthesia management.

Portal hypertension assessment is mandatory: The presence of CSPH fundamentally changes risk stratification and may contraindicate major resection even with adequate FLR 2, 5.